Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer
PaperCitations, authors & open-access status
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 202 citations, 2021 year and hybrid oa status.
202
Citations
2021
Year
hybrid
OA Status